Clinical Pharmacokinetics and Safety of a 10% Aminolevulinic Acid Hydrochloride Nanoemulsion Gel (BF‐200 ALA) in Photodynamic Therapy of Patients Extensively Affected With Actinic Keratosis: Results of 2 Maximal Usage Pharmacokinetic Trials

The nanoemulsion‐based 10% aminolevulinic acid (ALA) hydrochloride gel BF‐200 ALA optimizes epidermal penetration of its active ingredient and is approved for topical photodynamic therapy (PDT) for the treatment of actinic keratosis in the United States and Europe. To characterize systemic absorptio...

Descripción completa

Detalles Bibliográficos
Autores principales: Novak, Ben, DuBois, Janet, Chahrour, Osama, Papusha, Tamara, Hirt, Stefan, Philippi, Thomas, Zogel, Corinna, Osenberg, Katharina, Schmitz, Beate, Lübbert, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293336/
https://www.ncbi.nlm.nih.gov/pubmed/34633154
http://dx.doi.org/10.1002/cpdd.1023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293336/
https://www.ncbi.nlm.nih.gov/pubmed/34633154
http://dx.doi.org/10.1002/cpdd.1023

Ejemplares similares